Form 8-K - Current report:
SEC Accession No. 0000917520-21-000029
Filing Date
2021-05-18
Accepted
2021-05-18 16:32:36
Documents
14
Period of Report
2021-05-14
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K iart-20210514.htm   iXBRL 8-K 59383
2 EX-10.1 ex101.htm EX-10.1 143132
  Complete submission text file 0000917520-21-000029.txt   397751

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT iart-20210514.xsd EX-101.SCH 2237
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT iart-20210514_def.xml EX-101.DEF 14639
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT iart-20210514_lab.xml EX-101.LAB 28209
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT iart-20210514_pre.xml EX-101.PRE 15146
7 EXTRACTED XBRL INSTANCE DOCUMENT iart-20210514_htm.xml XML 10538
Mailing Address 1100 CAMPUS ROAD PRINCETON NJ 08540
Business Address 1100 CAMPUS ROAD PRINCETON NJ 08540 6092750500
INTEGRA LIFESCIENCES HOLDINGS CORP (Filer) CIK: 0000917520 (see all company filings)

EIN.: 510317849 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26224 | Film No.: 21936490
SIC: 3841 Surgical & Medical Instruments & Apparatus